These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32271041)

  • 1. Switching cluster membership in cluster randomized control trials: Implications for design and analysis.
    Schweig JD; Pane JF; McCaffrey DF
    Psychol Methods; 2020 Aug; 25(4):516-534. PubMed ID: 32271041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study.
    Candlish J; Teare MD; Dimairo M; Flight L; Mandefield L; Walters SJ
    BMC Med Res Methodol; 2018 Oct; 18(1):105. PubMed ID: 30314463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of treatment effects in matched-pair cluster randomized trials by calibrating covariate imbalance between clusters.
    Wu Z; Frangakis CE; Louis TA; Scharfstein DO
    Biometrics; 2014 Dec; 70(4):1014-22. PubMed ID: 25163648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intent-to-treat analysis of cluster randomized trials when clusters report unidentifiable outcome proportions.
    DeSantis SM; Li R; Zhang Y; Wang X; Vernon SW; Tilley BC; Koch G
    Clin Trials; 2020 Dec; 17(6):627-636. PubMed ID: 32838555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imputation strategies for missing continuous outcomes in cluster randomized trials.
    Taljaard M; Donner A; Klar N
    Biom J; 2008 Jun; 50(3):329-45. PubMed ID: 18537126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimum number of clusters and comparison of analysis methods for cross sectional stepped wedge cluster randomised trials with binary outcomes: A simulation study.
    Barker D; D'Este C; Campbell MJ; McElduff P
    Trials; 2017 Mar; 18(1):119. PubMed ID: 28279222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mixed model for repeated measures for cluster randomized trials: a simulation study investigating bias and type I error with missing continuous data.
    Bell ML; Rabe BA
    Trials; 2020 Feb; 21(1):148. PubMed ID: 32033617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiplicative treatment effects in randomized pretest-posttest experimental designs.
    Liu Q; Maxwell SE
    Psychol Methods; 2020 Feb; 25(1):71-87. PubMed ID: 31192625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichotomizing partial compliance and increased participant burden in factorial designs: the performance of four noncompliance methods.
    Merrill PD; McClure LA
    Trials; 2015 Nov; 16():523. PubMed ID: 26573840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of varying cluster size in cross-sectional stepped-wedge cluster randomised trials.
    Martin JT; Hemming K; Girling A
    BMC Med Res Methodol; 2019 Jun; 19(1):123. PubMed ID: 31200640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling clustering and treatment effect heterogeneity in parallel and stepped-wedge cluster randomized trials.
    Hemming K; Taljaard M; Forbes A
    Stat Med; 2018 Mar; 37(6):883-898. PubMed ID: 29315688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best (but oft-forgotten) practices: designing, analyzing, and reporting cluster randomized controlled trials.
    Brown AW; Li P; Bohan Brown MM; Kaiser KA; Keith SW; Oakes JM; Allison DB
    Am J Clin Nutr; 2015 Aug; 102(2):241-8. PubMed ID: 26016864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How large are the consequences of covariate imbalance in cluster randomized trials: a simulation study with a continuous outcome and a binary covariate at the cluster level.
    Moerbeek M; van Schie S
    BMC Med Res Methodol; 2016 Jul; 16():79. PubMed ID: 27401771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using audit information to adjust parameter estimates for data errors in clinical trials.
    Shepherd BE; Shaw PA; Dodd LE
    Clin Trials; 2012 Dec; 9(6):721-9. PubMed ID: 22848072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.
    Greenland S; Lanes S; Jara M
    Clin Trials; 2008; 5(1):5-13. PubMed ID: 18283074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalized estimating equations in cluster randomized trials with a small number of clusters: Review of practice and simulation study.
    Huang S; Fiero MH; Bell ML
    Clin Trials; 2016 Aug; 13(4):445-9. PubMed ID: 27094487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomization inference for balanced cluster-randomized trials.
    Raab GM; Butcher I
    Clin Trials; 2005; 2(2):130-40. PubMed ID: 16279135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal and repeated cross-sectional cluster-randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods.
    Localio AR; Berlin JA; Have TR
    Stat Med; 2006 Aug; 25(16):2720-36. PubMed ID: 16345043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.